Functional Electronic Stimulated Rehabilitation Application for Treatment in patients with cerebrovascular disorders

Kobayashi Yasuyo0 sites16 target enrollmentFebruary 1, 2022

Overview

No summary available.

Registry

who.int

Start Date

February 1, 2022

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Kobayashi Yasuyo

•1\. Within 1 month of cerebrovascular event (cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage)
•2\. With upper limb Brunnstrom stage(BRS)2\-4
•3\. Who are 20 years of age or older at the time of obtaining informed consent
•4\. Whose consent to participate in this clinical study and the informed consent of the patient have has been obtained in writing

•1\. Received treatments, such as botulinum therapy, repeated transcranial magnetic stimulation, transcranial direct current stimulation within 90 days of obtaining consent
•2\. With a history of surgery(including device therapy)or intravenous t\-PA for cerebrovascular event (cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage)
•3\.Cognitive decline(Mini\-Mental State Examination(MMSE)is 21 or less)
•4\.Severe skin symptoms on the affected upper limb
•5\.Have a history of epileptic seizures
•6\.With a history of substance abuse or addiction(including alcoholism)at the time of enrollment and within the past year, or patients with complications
•7\.Using an implantable cardiac stimulator such as a cardiac pacemaker or an implantable assisted heart
•8\.Using deep brain stimulation
•9\.With metal(excluding titanium products)implanted in the affected upper limb
•10\.Who are pregnant or may become pregnant